The Effects of His Bundle Pacing Compared to Classic Resynchronization Therapy in Patients with Pacing-Induced

Rafal Gardas1,2, Krzysztof S Golba1,2, Tomasz Soral1

  • 1Department of Electrocardiology, Leszek Giec Upper-Silesian Medical Centre, Silesian Medical University, 40-055 Katowice, Poland.

Insights

His bundle pacing (HBP) offers a superior alternative to biventricular pacing (BVP) for patients with pacing-induced cardiomyopathy (PICM) undergoing cardiac resynchronization therapy (CRT) upgrades. HBP demonstrated greater improvements in QRS duration, clinical outcomes, and left ventricular function.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiovascular Medicine

Background:

  • Pacing-induced cardiomyopathy (PICM) is a common complication of right ventricular pacing.
  • Cardiac resynchronization therapy (CRT) is the recommended treatment for PICM.
  • His bundle pacing (HBP) offers a potential alternative to biventricular pacing (BVP) by restoring synchronous ventricular activation.

Purpose of the Study:

  • To evaluate the efficacy of His bundle pacing (HBP) compared to biventricular pacing (BVP) in patients with pacing-induced cardiomyopathy (PICM) undergoing cardiac resynchronization therapy (CRT) upgrade.
  • To assess improvements in electrocardiographic, clinical, and echocardiographic parameters following HBP versus BVP.

Main Methods:

  • A prospective cohort study included patients with PICM scheduled for CRT upgrade.
  • Patients received either His bundle pacing (HBP) or biventricular pacing (BVP).
  • Measurements of QRS duration, New York Heart Association (NYHA) class, left ventricular ejection fraction (LVEF), and left ventricle reverse remodeling were recorded at baseline and six-month follow-up.

Main Results:

  • His bundle pacing (HBP) was successful in 83% of patients.
  • HBP resulted in a significantly greater reduction in QRS duration compared to BVP (118.3 ms vs. 150.5 ms).
  • Improvements in NYHA class, LVEF, and left ventricle reverse remodeling were more pronounced with HBP than with BVP.

Conclusions:

  • His bundle pacing (HBP) is a viable and effective alternative to biventricular pacing (BVP) for cardiac resynchronization therapy (CRT) upgrades in patients with pacing-induced cardiomyopathy (PICM).
  • HBP facilitates more significant improvements in ventricular synchrony, clinical status, and cardiac structure compared to BVP.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
103
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
108
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
65
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
21
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
686